Teicher BA - Search Results

1

LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.

Keyes KA, Mann L, Sherman M, Galbreath E, Schirtzinger L, Ballard D, Chen YF, Iversen P, Teicher BA. Keyes KA, et al. Among authors: teicher ba. Cancer Chemother Pharmacol. 2004 Feb;53(2):133-40. doi: 10.1007/s00280-003-0713-x. Epub 2003 Oct 31. Cancer Chemother Pharmacol. 2004. PMID: 14593497

2

Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.

Teicher BA, Wong JS, Takeuchi H, Gravelin LM, Ara G, Buxton D. Teicher BA, et al. Cancer Chemother Pharmacol. 1998;42(1):24-30. doi: 10.1007/s002800050780. Cancer Chemother Pharmacol. 1998. PMID: 9619754

3

Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy.

Teicher BA, Alvarez E, Mendelsohn LG, Ara G, Menon K, Ways DK. Teicher BA, et al. Adv Enzyme Regul. 1999;39:313-27. doi: 10.1016/s0065-2571(98)00026-0. Adv Enzyme Regul. 1999. PMID: 10470381

4

Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.

Liu P, Menon K, Alvarez E, Lu K, Teicher BA. Liu P, et al. Among authors: teicher ba. Int J Oncol. 2000 Mar;16(3):599-610. doi: 10.3892/ijo.16.3.599. Int J Oncol. 2000. PMID: 10675495

5

Antitumor activity of cryptophycins: effect of infusion time and combination studies.

Menon K, Alvarez E, Forler P, Phares V, Amsrud T, Shih C, Al-Awar R, Teicher BA. Menon K, et al. Among authors: teicher ba. Cancer Chemother Pharmacol. 2000;46(2):142-9. doi: 10.1007/s002800000135. Cancer Chemother Pharmacol. 2000. PMID: 10972484

6

Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents.

Lu K, Shih C, Teicher BA. Lu K, et al. Among authors: teicher ba. Cancer Chemother Pharmacol. 2000;46(4):293-304. doi: 10.1007/s002800000136. Cancer Chemother Pharmacol. 2000. PMID: 11052627

7

Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells.

Lu K, Dempsey J, Schultz RM, Shih C, Teicher BA. Lu K, et al. Among authors: teicher ba. Cancer Chemother Pharmacol. 2001;47(2):170-8. doi: 10.1007/s002800000210. Cancer Chemother Pharmacol. 2001. PMID: 11269744

8

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.

Teicher BA, Menon K, Alvarez E, Galbreath E, Shih C, Faul M. Teicher BA, et al. Clin Cancer Res. 2001 Mar;7(3):634-40. Clin Cancer Res. 2001. PMID: 11297259

9

Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.

Teicher BA, Menon K, Alvarez E, Liu P, Shih C, Faul MM. Teicher BA, et al. In Vivo. 2001 May-Jun;15(3):185-93. In Vivo. 2001. PMID: 11491013

10

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in murine lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts.

Teicher BA, Menon K, Alvarez E, Galbreath E, Shih C, Faul MM. Teicher BA, et al. Cancer Chemother Pharmacol. 2001 Dec;48(6):473-80. doi: 10.1007/s002800100372. Cancer Chemother Pharmacol. 2001. PMID: 11800028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters